Aegle Therapeutics isolates extracellular vesicles (EVs) secreted by allogeneic bone marrow derived mesenchymal stem cells (BM-MSCs) to treat severe dermatological conditions including burns and epidermolysis bullosa (EB), a rare pediatric connective tissue disorder. Its proprietary extracellular vesicle isolation technology allows them to harness the healing power of mesenchymal stem cells without the risk of cell proliferation or engraftment, with higher production yields and at a lower cost.
Active
January 2020
Employees: 11-50
Total raised: $10.5M
Founded date: 2019
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 30.09.2020 | Series A | $6.5M | - |
| 08.01.2020 | - | $4M | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 13.02.2024 | Meet February Pitch Presenter Aegle Therapeutics’ Shelley Ha... | Last year was a very good year for VisionTech. Applying strict criteria, we completed 18 deals worth... | visiontech... |
| 21.07.2021 | Ocean Azul closes Fund 2 at over $40 million, with a South F... | Facebook Tweet Pin LinkedIn Email Ocean Azul Partners, a Miami-based early-stage venture firm, annou... | refreshmia... |
| 02.12.2020 | Aegle Therapeutics’ big mission: Tackling a horrific pediatr... | Facebook Tweet Pin LinkedIn Email Dr. Evangelos Badiavas, a dermatologist at the University of Miami... | refreshmia... |
| 18.11.2020 | Q&A with David Zinn of Ocean Azul: A global fund, yet so... | Facebook Tweet Pin LinkedIn Email Coral Gables-based venture firm Ocean Azul has invested in 19 star... | refreshmia... |
| 30.09.2020 | Aegle, a Miami biotech startup, raises $6.5 million Series A... | Facebook Tweet Pin LinkedIn Email Aegle Therapeutics, a Miami biotechnology startup, today announced... | refreshmia... |
| 30.09.2020 | Aegle Therapeutics Closes $6.5M Series A Financing | Aegle Therapeutics Corporation, an Arlington and Miami-based biotechnology company developing extrac... | finsmes.co... |
| 29.09.2020 | Aegle Therapeutics Completes $6.5M Series A | Aegle Therapeutics Corporation, a first-in-class biotechnology company developing extracellular vesi... | citybizlis... |
| 08.01.2020 | Miami biotech startup Aegle Therapeutics draws $4M investmen... | Facebook Tweet Pin LinkedIn Email CEO Shelley Hartman Aegle Therapeutics, a biotech startup that spr... | refreshmia... |
| 07.01.2020 | Aegle Therapeutics Announces $4M Financing | Aegle Therapeutics Corp., a first in class biotechnology company isolating extracellular vesicles, i... | citybizlis... |
| 07.01.2020 | Aegle Therapeutics Announces $4M Financing | MIAMI, FL, Aegle Therapeutics today announced the closing of a $4M financing. >> Click here... | vcnewsdail... |
Show more